BIO-KEY INTERNATIONAL INC (BKYI)

US09060C5076 - Common Stock

1.7  +0.01 (+0.59%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024
Revenue
YoY % growth
2.84M
25.11%		5.11M
79.93%		7.02M
37.38%		10.2M
45.30%
EBITDA
YoY % growth
-4.99M
10.73%		-4.66M
6.61%		-7.64M
-63.95%		N/AN/A
EBIT
YoY % growth
-5.2M
20.73%		-4.94M
5.00%		-8.03M
-62.55%		-6.477M
19.34%
Operating Margin
-183.10%-96.67%-114.39%-63.50%
EPS
YoY % growth
-2.66
33.50%		-0.63
76.32%		-7.82
-1,141.27%		-0.89
88.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23
EPS
Q2Q % growth		-0.17
97.59%
Revenue
Q2Q % growth		3.213M
82.56%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-1.244M
59.99%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -2.88
-1,271.43%		-4.221.3431.80%
Q1 2023
Q2Q % growth		 -1.44
-1,100.00%		-4.963.5270.95%
Q4 2022
Q2Q % growth		 -7.20
-2,669.23%		-4.96-2.24-45.24%
Q3 2022
Q2Q % growth		 -0.29
-123.08%		-0.16-0.13-77.70%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 1.817M
32.64%		2.601M-783.89K-30.14%
Q2 2023
Q2Q % growth		 1.93M
-1.03%		2.346M-416K-17.73%
Q1 2023
Q2Q % growth		 3.08M
58.76%		2.04M1.04M50.98%
Q4 2022
Q2Q % growth		 1.76M
89.25%		1.775M-15K-0.85%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%